3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Interventions
Nivolumab
8
belzutifan
7
pembrolizumab
6
Ipilimumab
5
cabozantinib
3
Surveys and Questionnaires
3
lenvatinib
2
Radiosurgery
2
Paclitaxel
2
Everolimus
2
Carboplatin
2
pazopanib
1
palbociclib
1
liposomal doxorubicin
1
guadecitabine
1
fludarabine phosphate
1
endothelial PAS domain-containing protein 1
1
durvalumab
1
cemiplimab
1
atezolizumab
1
aldesleukin
1
X-Rays
1
Technetium Tc 99m Sestamibi
1
Taxes
1
Sunitinib
1
Spermine Synthase
1
Social Determinants of Health
1
Single Photon Emission Computed Tomography Computed Tomography
1
Radiotherapy
1
Radionuclide Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Kidney Neoplasms
×
Biopsy, Large-Core Needle
×
Clear all
NCT05520099
2026-04-29
ELEPHAS-02
Elephas
Active not recruiting
416 enrolled